Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Final Provider-Administered Oncology Drugs .

print Print Back Back Kymriah (tisagenlecleucel) (Intravenous) Policy Number: VP-0319   Intravenous ...

print Print Back Back Yescarta™ (axicabtagene ciloleucel) (Intravenous) Policy Number: VP-0333 ​   ...

print Print Back Back Tecartus™ (brexucabtagene autoleucel) (Intravenous) Policy Number: VP-0558 ...

print Print Back Back Breyanzi® (lisocabtagene maraleucel) (Intravenous) Policy Number: VP-0590    ...

print Print Back Back Abecma® (idecabtagene vicleucel) (Intravenous) Policy Number: VP-0598    ...

print Print Back Back Adstiladrin® (nadofaragene firadenovec-vncg) (Intravesical) Policy Number: VP-0691 Last...

Breyanzi